Skip to main content
SpringerLink
Log in

Toremifene: an exciting new antiestrogen for postmenopausal breast cancer

  • New Drugs and Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wiseman LR, Goa KL. Toremifene: a review of its pharmacological properties and clinical efficacy in the management of advanced breast cancer. Drugs 1997 Jul; 54(1): 141–160

    Article  PubMed  CAS  Google Scholar 

  2. Hayes DF, Van Zyl JA, Hacking A, et al. Randomised comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer. J Clin Oncol 1995; 13: 2556–66

    PubMed  CAS  Google Scholar 

  3. PyrhöF6;nen S, Valavaara R, Modig H, et al. Comparison of toremifene and tamoxifen in postmenopausal patients with advanced breast cancer: a randomised double blind, the ‘Nordic’ phase III study. Br J Cancer 1997; 76: 270–7

    Article  PubMed  Google Scholar 

  4. Gershanovich M, Garin A, Baltina D, et al. A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer. Breast Cancer Res Treat. In press

  5. Stenbygaard LE, Herrstedt J, Thomsen JF, et al. Toremifene and tamoxifen in advanced breast cancer — a double-blind cross-over trial. Breast Cancer Res Treat 1993; 25(1): 57–63

    Article  PubMed  CAS  Google Scholar 

  6. Asaishi K, Tominaga T, Abe O, et al. Efficacy and safety of high dose NK 622 (toremifene citrate) in tamoxifen failed patients with breast cancer [in Japanese]. Gan to Kagaku Ryoho 1993; 20: 91–9

    PubMed  CAS  Google Scholar 

  7. Jönsson PE, Malmberg M, Bergljung L, et al. Phase-II study of high dose toremifene in advanced breast cancer progressing during tamoxifene treatment. Anticancer Res 1991; 11: 873–6

    PubMed  Google Scholar 

  8. Pyrhönen S, Valavaara R, Vuorinen J, et al. High dose toremifene in advanced breast cancer resistant to or relapsed during tamoxifen treatment. Breast Cancer Res Treat 1994; 29(3): 223–8

    Article  PubMed  Google Scholar 

  9. Vogel CL, Shemano I, Schoenfelder J, et al. Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancer. J Clin Oncol 1993; 11: 345–50

    PubMed  CAS  Google Scholar 

  10. British National Formulary No. 33. London: The Pharmaceutical Press, 1997 Mar: 372–4; 569-70

  11. PDR Generics. 3rd ed. Montvale NJ: Medical Economics, 1997: 2910–3

  12. Plotkin D, Lechner JJ, Jung WE, et al. Tamoxifen flare in advanced breast cancer. Journal American Medical Association 1978; 240: 2644–6

    Article  CAS  Google Scholar 

  13. Saarto T, Blomqvist C, Vällmäki M, et al. Clodronate improves bone mineral density in postmenopausal breast cancer patients treated with adjuvant antioestrogens. Br J Cancer 1997; 75: 602–5

    Article  PubMed  CAS  Google Scholar 

  14. Rutqvist LE, Johansson H, Signomklao T, et al. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. J Natl Cancer Inst 1995; 87: 645–51

    Article  PubMed  CAS  Google Scholar 

  15. Fornander T, Rutqvist LE, Cedermark B, et al. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1989; i: 117–20

    Article  Google Scholar 

  16. Fisher B, Costantino JP, Redmond CK, et al. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994; 86: 527–37

    Article  PubMed  CAS  Google Scholar 

  17. Jordan VC. Alternate antiestrogens and approaches to the prevention of breast cancer. J Cell Biochem 1995; 22: 51–7

    Article  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Toremifene: an exciting new antiestrogen for postmenopausal breast cancer. Drugs Ther. Perspect 10, 1–5 (1997). https://doi.org/10.2165/00042310-199710110-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199710110-00001

Keywords

Search

Navigation